Humacyte Announces Presentation of First Preclinical
DURHAM, N.C., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally...
Source: globenewswire.com
Stay updated with breaking news from Nasdaq Huma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DURHAM, N.C., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally...